Polydatin Injectable (HW6) for Shock Treatment

Clinical trial NCT01780129 · UNKNOWN

Trial details

NCT number: NCT01780129
Sponsor: Neptunus Pharmaceuticals Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Shock, Hemorrhagic Shock, Traumatic Shock, Septic

Start date: 2013-02-01
Primary completion: 2014-09-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.